CarThera

About

CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders.

Paris,Ile-de-France,France
1 - 10

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: €10.50M
Industries: Biotechnology,Health Care,Medical Device,Therapeutics
Founded date: Jan 1, 2010
Number Of Employee: 1 - 10
Operating Status: Active

CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reach the brain.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

€29.30M

CarThera has raised a total of €29.30M in funding over 2 rounds. Their latest funding was raised on Sep 14, 2020 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 14, 2020	Series C	€10.50M	1	European Innovation Council	—	Detail
Sep 14, 2020	Grant	€2M	1	European Innovation Council	—	Detail
Dec 12, 2018	Series B	€9M	4	—	—	Detail
Oct 12, 2016	Grant	€5.70M	—	—	—	Detail
Apr 13, 2015	Series A	€2.10M	—	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

6

CarThera is funded by 6 investors. European Innovation Council and Groupe Arnault are the most recent investors.

Investor Name	Lead Investor	Funding Round
European Innovation Council	Yes	Series C
Groupe Arnault	—	Series B
Panakes Partners	—	Series B
Sham Innovation Santé	—	Series B
Supernova Invest	—	Series B
AGORANOV	—	Seed